Laurel Wealth Advisors (California)’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
CS
Laurel Wealth Advisors (California)'s GH Position: Q4 2022 in Review
Laurel Wealth Advisors (California) sold out of Guardant Health (GH) in Q4 2022, closing a stake of 4,224 shares — an estimated $227K sold.
Laurel Wealth Advisors (California) first reported a position in GH in Q4 2021 and held it in 3 quarters. The position peaked at $346K in Q4 2021. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.
- Laurel Wealth Advisors (California) reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
- Laurel Wealth Advisors (California) sold 4,224 Guardant Health shares in Q4 2022, an estimated $227K.
- Laurel Wealth Advisors (California) first reported a position in Guardant Health in Q4 2021 and held it in 3 quarters.
- Laurel Wealth Advisors (California)'s Guardant Health position peaked at $346K in Q4 2021.
- 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.
Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.